Skip to content

Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-South Africa

Survey of Procedures and Resources for Initiating Treatment of HIV in Africa: The SPRINT Study in South Africa

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04170374
Acronym
SPRINT-SA
Enrollment
831
Registered
2019-11-20
Start date
2020-11-01
Completion date
2024-12-01
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antiretroviral Therapy, HIV

Brief summary

In its 2017 revision of the global guidelines for HIV care and treatment, the World Health Organization called for rapid or same-day initiation of antiretroviral treatment (ART) for eligible patients testing positive for HIV. The South African National Department of Health adopted this recommendation in October 2017. Neither organization provided detailed guidance, however, on how to implement the recommendation. In sub-Saharan Africa, where most HIV patients are located, studies continue to document high losses of treatment-eligible patients from care before they receive their first dose of antiretroviral medications (ARVs). Among facility-level reasons for these losses are treatment initiation protocols that require multiple clinic visits and long waiting times before a patient who tests positive for HIV is dispensed an initial supply of medications. There is very little published evidence on the practical details of the process and the extent to which it varies by facility, setting, or country. Without a robust baseline evidence base, it is challenging to identify opportunities for making improvements. The SPRINT (Survey of Procedures and Resources for Initiating Treatment of HIV in Africa) study will begin to develop this evidence base. SPRINT will combine a facility-level description of the standard of care with a retrospective record review of patients who recently initiated ART at the study sites. Data will be collected from 12 clinics across 3 provinces in South Africa (KwaZuluNatal Province, Gauteng Province, and Limpopo Province). The survey will elicit detailed information about current procedures through structured interviews with clinic staff. The record review for a retrospective cohort of patients eligible for ART will estimate actual numbers of clinic visits, services provided, and duration of the steps for treatment initiation from start to finish. SPRINT is expected to identify differences in approaches to treatment initiation and potential opportunities for improvement.

Interventions

The study will collect routine medical record data from the electronic medical record system, other electronic databases, and paper charts.

Clinicians and lay staff will be interviewed regarding the ART initiation process.

Sponsors

Bill and Melinda Gates Foundation
CollaboratorOTHER
University of Witwatersrand, South Africa
CollaboratorOTHER
Boston University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years old * HIV-positive

Exclusion criteria

* Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Average numbers of visits required to start ARTUp to 6 months after treatment eligibility determinedNumber of health system interactions required between HIV diagnosis and first dispensing of ARVs
Time to ART initiationUp to 6 months after treatment eligibility determinedAverage number of days required between HIV diagnosis and first dispensing

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026